This company has shut down. Micronoma is no longer operating — its last tracked round was a Convertible Note in 2022.
Explore the Startup GraveyardMicronoma is a cancer detection biotech company.
Micronoma has raised $11.0M in total funding. The most recent round was Convertible Note. The last funding was announced in March 2022.
Micronoma's investors include SymBiosis LLC, Seerave Foundation.
Micronoma is headquartered in San Diego, United States.
Micronoma is a cancer detection biotech company.
Micronoma is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Micronoma — Funding & Investors." VCBacked, March 31, 2022, https://www.vcbacked.co/company/micronoma. Accessed August 14, 2026.
VCBacked. (2022). Micronoma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/micronoma
{{cite web |title=Micronoma — Funding & Investors |url=https://www.vcbacked.co/company/micronoma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated